Home Capital Market United States & Hong Kong Biotech Company Insilico Medicine Raised $123 Million...

United States & Hong Kong Biotech Company Insilico Medicine Raised $123 Million in Series E Funding at $1 Billion Valuation, Increased Series E Funding Round from $110 Million Announced in 2025 March, Plans Hong Kong IPO, Founded in 2014 by Alex Zhavoronkov & Alex Aliper, Investors Include Value Partners, Warburg Pincus, B Capital Group, Eli Lilly & Co Venture Unit, Qiming Venture Partners & Wuxi AppTec

Jun 17, 2025

Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets? Caproasia - Learn more

2025 Summits in Hong Kong & Singapore
Investment / Alternatives Summit - March / Oct / Nov
Investment Day - March / July / Sept / Oct / Nov
Private Wealth Summit - April / Oct / Nov
Family Office Summit - April / Oct / Nov
View Events | Register

This site is for accredited investors, professional investors, investment managers and financial professionals only. You should have assets around $3 million to $300 million or managing $20 million to $30 billion.

United States & Hong Kong Biotech Company Insilico Medicine Raised $123 Million in Series E Funding at $1 Billion Valuation, Increased Series E Funding Round from $110 Million Announced in 2025 March, Plans Hong Kong IPO, Founded in 2014 by Alex Zhavoronkov & Alex Aliper, Investors Include Value Partners, Warburg Pincus, B Capital Group, Eli Lilly & Co Venture Unit, Qiming Venture Partners & Wuxi AppTec

17th June | Hong Kong

United States & Hong Kong biotech company Insilico Medicine has raised $123 million in Series E funding at $1 billion valuation, an increase in Series E funding round from $110 million announced in 2025 March. In June 2025, United States & Hong Kong biotech company Insilico Medicine is planning a Hong Kong IPO after raising $110 million in Series E funding at $1 billion valuation in 2025 March. Insilico Medicine was founded in 2014 by Alex Zhavoronkov & Alex Aliper. Insilico Medicine investors include Value Partners, Warburg Pincus, B Capital Group, Eli Lilly & Co Venture Unit, Qiming Venture Partners & Wuxi AppTec. Profile – Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.

“ United States & Hong Kong Biotech Company Insilico Medicine Raised $123 Million in Series E Funding at $1 Billion Valuation, Increased Series E Funding Round from $110 Million Announced in 2025 March, Plans Hong Kong IPO, Founded in 2014 by Alex Zhavoronkov & Alex Aliper, Investors Include Value Partners, Warburg Pincus, B Capital Group, Eli Lilly & Co Venture Unit, Qiming Venture Partners & Wuxi AppTec “

- Article continues below -

Sign Up
Basic Member: $5 Monthly | $60 Yearly
Newsletter Daily 2 pm (Promo): $20 Monthly | $180 Yearly (FP: $680)

The 2025 Investment Day
Hong Kong | Singapore
March / July / Sept / Oct / Nov
Private Equity, Hedge Funds, Boutique Funds, Private Markets & more. Join 20+ CIOs & Senior investment team, with > 60% single family offices with $300 million AUM. Taking place in Hong Kong and in Singapore. Every March, July, Sept, Oct & Nov.
Visit | Register here

The 2025 Family Office Summit
10th April & 16th Oct Hong Kong Ritz Carlton | 24th April & 6th Nov Singapore Amara Sanctuary Resort
Join 80 single family offices & family office professionals in Hong Kong & Singapore
Links: 2025 Family Office Summit | Register here

2025 Investment / Alternatives Summit
March / Oct / Nov in Hong Kong & Singapore
Join leading asset managers, hedge funds, boutique funds, private equity, venture capital & real estate firms in Hong Kong, Singapore & Asia-Pacific at the Investment / Alternatives Summit. Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here

2025 Private Wealth Summit
April / Oct / Nov in Hong Kong & Singapore
Join CEOs, CIOs, Head of Private Banking, Head of Family Offices & Product Heads at The Private Wealth Summit. Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here

United States & Hong Kong Biotech Company Insilico Medicine Plans Hong Kong IPO after Raising $110 Million in Series E Funding at $1 Billion Valuation, Founded in 2014 by Alex Zhavoronkov & Alex Aliper, Investors Include Value Partners, Warburg Pincus, B Capital Group, Eli Lilly & Co Venture Unit, Qiming Venture Partners & Wuxi AppTec

Hong Kong | Leading Financial Centre in Asia

5th June – United States & Hong Kong biotech company Insilico Medicine is planning a Hong Kong IPO after raising $110 million in Series E funding at $1 billion valuation. Insilico Medicine was founded in 2014 by Alex Zhavoronkov & Alex Aliper. Insilico Medicine investors include Value Partners, Warburg Pincus, B Capital Group, Eli Lilly & Co Venture Unit, Qiming Venture Partners & Wuxi AppTec. Profile – Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.

Managing $20 million to $3 billion. Investing $3 million to $300 million.
For Investment Managers, Hedge Funds, Boutique Funds, Private Equity, Venture Capital, Professional Investors, Family Offices, Private Bankers & Advisors, sign up today. Subscribe to Caproasia and receive the latest news, data, insights & reports, events & programs daily at 2 pm.

Join Events & Find Services
Join Investments, Private Wealth, Family Office events in Hong Kong, Singapore, Asia-wide. Find hard-to-find $3 million to $300 million financial & investment services at The Financial Centre | TFC. Find financial, investment, private wealth, family office, real estate, luxury investments, citizenship, law firms & more. List hard-to-find financial & private wealth services.

Have a product launch? Promote a product or service? List your service at The Financial Centre | TFC. Join interviews & editorial and be featured on Caproasia.com or join Investments, Private Wealth, Family Office events. Contact us at [email protected] or [email protected]

Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets?

Quick Links

2021 Data Release
2020 List of Private Banks in Hong Kong
2020 List of Private Banks in Singapore
2020 Top 10 Largest Family Office
2020 Top 10 Largest Multi-Family Offices
2020 Report: Hong Kong Private Banks & Asset Mgmt - $4.49 Trillion
2020 Report: Singapore Asset Mgmt - $3.48 Trillion AUM

For Investors | Professionals | Executives
Latest data, reports, insights, news, events & programs
Everyday at 2 pm
Direct to your inbox
Save 2 to 8 hours per week. Organised for success

Register Below

For CEOs, Heads, Senior Management, Market Heads, Desk Heads, Financial Professionals, Investment Managers, Asset Managers, Fund Managers, Hedge Funds, Boutique Funds, Analysts, Advisors, Wealth Managers, Private Bankers, Family Offices, Investment Bankers, Private Equity, Institutional Investors, Professional Investors

Get Ahead in 60 Seconds. Join 10,000 +
Save 2 to 8 hours weekly. Organised for Success.

Sign Up / Register

Web links may be disabled on mobile for security.
Please click on desktop.

New to Caproasia
Learn More | Sign Up | Subscribe | Register Events

Caproasia Users

Manage $20 million to $3 billion of assets
Invest $3 million to $300 million
Advise institutions, billionaires, UHNWs & HNWs

Caproasia Platforms | 11,000 Investors & Advisors

Monthly Roundtable & Networking

Family Office Programs

The 2025 Investment Day

March - Hong Kong
March - Singapore
July - Hong Kong
July - Singapore
Sept- Hong Kong
Sept - Singapore
Oct- Hong Kong
Nov - Singapore
Visit: The Investment Day | Register: Click here

Caproasia Summits

Contact Us

For Enquiries, Membership
[email protected], [email protected]

For Listing, Subscription
[email protected], [email protected]

For Press Release, send to:
[email protected]

For Events & Webinars
[email protected]

For Media Kit, Advertising, Sponsorships, Partnerships
[email protected]

For Research, Data, Surveys, Reports
[email protected]

For General Enquiries
[email protected]

Caproasia | Driving the future of Asia
a financial information technology co.
since 2014